Reference Listed Drug supplier- Ikris Pharma Network

Reference Listed Drug (RLD) specifically is an approved drug product to which new generic versions are compared in order to show that they are bioequivalent.

A drug company seeking approval to market a generic equivalent must refer to the reference listed drug (RLD) in its regulatory consents.
Ikris Pharma Network can source as well as supply reference listed drugs.

The mark of a reference listed drug as a typical excellence to which the generic version must be demonstrated to be bioequivalent to ensure that strength, dosage, administration route, safety, characteristics, execution, acting and intended use are therapeutically equivalent based on the scientific evaluation and as such should have identical effect and no difference when substituted with the brand version.

Ikris Pharma, the leading reference listed drug supplier, always favours the development of generic drugs in order to ensure global market access with sourcing and supply of reference samples for research purpose.

Ikris Pharma can procure branded Innovator drugs/ Reference Listed Drugs (RLD) for bioequivalence and clinical trials from almost anywhere at the global level.

Ikris Pharma specialized in sourcing branded Innovator Samples / Reference Listed Drugs from single/multiple batches in appropriate quantities and the potential to supply the products that do not exist from most of the suppliers.

The potentialities of the company can source innovator samples from Different Global markets like the USA, Europe, Australia, Canada, Japan, Brazil, etc.

We ship temperature-controlled products in the required temperature if needed, we have a warehouse in Belgium which makes us more competitive in supplying reference listed products.